CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status

By                

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 562-568

Spandidos Publications

Access to resources Recommend Favorite

Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients

By Yamamoto Manabu   Baba Hideo   Toh Yasushi   Okamura Takeshi   Maehara Yoshihiko  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 7, 2007-07 ,pp. : 471-476

Springer Publishing Company

Access to resources Recommend Favorite

Reduction of Chemotherapy-induced Side-effects by Parenteral Glutamine Supplementation in Patients with Metastatic Colorectal Cancer

By Decker-Baumann C.   Buhl K.   Frohmuller S.   Herbay A.v.   Dueck M.   Schlag P.M.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 202-207

Elsevier

Access to resources Recommend Favorite

Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes

By Guo Qingqu   Kang Muxing   Zhang Bo   Chen Ying   Dong Xin   Wu Yulian  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1627-1631

Springer Publishing Company

Access to resources Recommend Favorite